Goldman Sachs India Equity ETF (GIND) Stock Price

21.4528 ▼ -0.3476 (-1.59%)
Open: 21.57 Vol: 1.76K Day's range: 21.43 - 21.59 Mar 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
GIND Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 22.24▼ 22.24▼ 22.24▼ 21.99▼ 22.34▼
MA10 22.75▼ 22.75▼ 22.75▼ 22.27▼ 23.84▼
MA20 23.69▼ 23.71▼ 23.71▼ 22.88▼ 24.99▼
MA50 24.92▼ 24.80▼ 24.75▼ 24.31▼ 26.00▼
MA100 25.11▼ 25.38▼ 25.44▼ 25.36▼ N/A    
MA200 25.81▼ 25.99▼ N/A     26.06▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.169▼ -0.176▼ -0.176▼ -0.060▼ -0.445▼
RSI 13.274▼ 14.553▼ 15.007▼ 28.355▼ 24.717▼
STOCH 4.468▼ 4.468▼ 4.468▼ 19.388▼ 6.184▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -98.888▼ -99.565▼
CCI -129.961▼ -129.961▼ -129.961▼ -173.777▼ -148.467▼
Latest Filters Detected On GIND
▼ RSI&STOCH $GIND Oversold RSI + Stochastic Set Alert
▼ RSI $GIND RSI(14) Crossed Below 30 Set Alert
▼ BREAK $GIND Price Breaks 60 Days Low Set Alert
▼ BREAK $GIND Price Breaks 30 Days Low Set Alert
▼ BREAK $GIND Price Breaks 20 Days Low Set Alert
▼ BREAK $GIND Price Breaks 10 Days Low Set Alert
Goldman Sachs India Equity ETF News
Gilead to acquire Ouro Medicines in $2.18B deal, expand inflammation pipeline
Thursday, March 26, 2026 05:55 PM
Gilead Sciences, Inc. (NASDAQ:GILD) is included among the Dividend Stock Portfolio for Income: 15 Stocks to Invest In. On March 23, The Wall Street Journal reported that Gilead Sciences, Inc.
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth
Tuesday, March 17, 2026 02:47 AM
Chief Financial Officer Andrew Dickinson told investors at the Barclays conference that the company is entering what he described as “the beginning of a long cycle,” supported by recent launches, a ...
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Sunday, March 15, 2026 02:52 PM
Gilead Sciences Inc. (NASDAQ:GILD) is one of Goldman Sachs top healthcare stocks. On March 10, Jefferies initiated coverage of Gilead Sciences Inc. (NASDAQ:GILD) with a Buy rating and a $180 price ...
GIND historical stock data
date open high low close volume
30/03/26 21.57 21.59 21.43 21.4528 1,758
27/03/26 21.78 21.84 21.76 21.8004 12,687
26/03/26 22.37 22.485 22.125 22.125 486
25/03/26 22.689 22.689 22.44 22.59 2,484
24/03/26 22.14 22.14 21.9923 21.9923 12,491
23/03/26 22.47 22.90 22.47 22.625 20,810
20/03/26 22.54 22.54 22.06 22.08 15,820
19/03/26 22.43 22.565 22.43 22.565 1,157
18/03/26 22.88 22.91 22.605 22.605 12,300
17/03/26 23.00 23.01 22.89 22.905 9,906
Quote Details
52wk Low:21.43
52wk High:29.52
Vol:1.76K
Avg Vol(3m):574.6K
1Y Chng:-13.14%
1M Chng:-16.35%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00